SIGNAL Underwriting is very pleased to announce that we are launching our revamped Life Sciences product for Biotechnology, Pharmaceutical, Medical Device, Nutraceutical and R&D and Services companies. The changes include a new market leading manuscript wording providing a breadth of coverages and in-house underwriting authority, further details of which can be viewed here Life Sciences (signalunderwriting.com).
"I am very excited about this change as it continues to support our mission of providing products where we hold the underwriting authority and offering customized products to niche market segments" commented Alexander Blair-Johns, CEO, SIGNAL Underwriting Inc.
Contact our office if you have any questions QuoteRequest@SignalUnderwriting.com